Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes

被引:151
作者
Varga, CM
Tedford, NC
Thomas, M
Klibanov, AM
Griffith, LG
Lauffenburger, DA
机构
[1] MIT, Biol Engn Div, Cambridge, MA 02139 USA
[2] MIT, Dept Chem, Cambridge, MA 02139 USA
[3] MIT, Dept Mech Engn, Cambridge, MA 02139 USA
[4] MIT, Ctr Biotechnol Proc Engn, Cambridge, MA 02139 USA
关键词
molecular conjugates; trafficking; mathematical model; liver;
D O I
10.1038/sj.gt.3302495
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An objective of designing molecular vehicles exhibiting virus-like transgene delivery capabilities but with low toxicity and immunogenicity continues to drive synthetic vector development. As no single step within the gene delivery pathway represents the critical limiting barrier for all vector types under all circumstances, improvements in synthetic vehicle design may be aided by quantitative analysis of the contributions of each step to the overall delivery process. To our knowledge, however, synthetic and viral gene delivery methods have not yet been explicitly compared in terms of these delivery pathway steps in a quantitative manner. As a first address of this challenge, we compare here quantitative parameters characterizing intracellular gene delivery steps for an E1/E3-deleted adenoviral vector and three polyethylenimine (PEI)-based vector formulations, as well as the liposomal transfection reagent Lipofectamine and naked DNA; the cargo is a plasmid encoding the beta-galactosidase gene under a CMV promoter, and the cell host is the C3A human hepatocellular carcinoma line. The parameters were determined by applying a previously validated mathematical model to transient time-course measurements of plasmid uptake and trafficking ( from whole-cell and isolated nuclei lysates, by real-time quantitative PCR), and gene expression levels, enabling discovery of those for which the adenoviral vector manifested superiority. Parameter-sensitivity analysis permitted identification of processes most critically rate-limiting for each vector. We find that the adenoviral vector advantage in delivery appears to reside partially in its import to the nuclear compartment, but that its vast superiority in transgene expression arises predominantly in our situation from postdelivery events: on the basis of per-nuclear plasmid, expression efficiency from adenovirus is superior by orders of magnitude over the PEI vectors. We find that a chemical modification of a PEI-based vector, which substantially improves its performance, appears to do so by enhancing certain trafficking rate parameters, such as binding and uptake, endosomal escape, and binding to nuclear import machinery, but leaves endosomal escape as a barrier over which transgene delivery could be most sensitively increased further for this polymer.
引用
收藏
页码:1023 / 1032
页数:10
相关论文
共 28 条
[1]   A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine [J].
Abdallah, B ;
Hassan, A ;
Benoist, C ;
Goula, D ;
Behr, JP ;
Demeneix, BA .
HUMAN GENE THERAPY, 1996, 7 (16) :1947-1954
[2]   Measuring the pH environment of DNA delivered using nonviral vectors: Implications for lysosomal trafficking [J].
Akinc, A ;
Langer, R .
BIOTECHNOLOGY AND BIOENGINEERING, 2002, 78 (05) :503-508
[3]   Receptors mediating adenovirus attachment and internalization [J].
Bergelson, JM .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (09) :975-979
[4]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[5]   On the kinetics of polyplex endocytic trafficking: Implications for gene delivery vector design [J].
Forrest, ML ;
Pack, DW .
MOLECULAR THERAPY, 2002, 6 (01) :57-66
[6]   ADENOVIRUS PRECURSOR TO TERMINAL PROTEIN INTERACTS WITH THE NUCLEAR MATRIX INVIVO AND INVITRO [J].
FREDMAN, JN ;
ENGLER, JA .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3384-3395
[7]  
Godbey WT, 2000, J BIOMED MATER RES, V51, P321, DOI 10.1002/1097-4636(20000905)51:3<321::AID-JBM5>3.0.CO
[8]  
2-R
[9]  
Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO
[10]  
2-Q